Lawrence Otto Klein's Net Worth

$26.9 Million

Estimate Recalculated Nov 1, 2024 05:20AM EST

Who is Lawrence Otto Klein?

Lawrence Otto Klein has an estimated net worth of $26.9 Million. This is based on reported shares across multiple companies, which include Dyne Therapeutics, Inc., CRISPR Therapeutics AG, Jasper Therapeutics, Inc., and Oruka Therapeutics, Inc..

SEC CIK

Lawrence Otto Klein's CIK is 0001762583

Past Insider Trading and Trends

2021 was Lawrence Otto Klein's most active year for acquiring shares with 17 total transactions. Lawrence Otto Klein's most active month to acquire stocks was the month of February. 2021 was Lawrence Otto Klein's most active year for disposing of shares, totalling 28 transactions. Lawrence Otto Klein's most active month to dispose stocks was the month of December. 2021 saw Lawrence Otto Klein paying a total of $3,750,475.16 for 275,991 shares, this is the most they've acquired in one year. In 2021 Lawrence Otto Klein cashed out on 274,925 shares for a total of $21,158,497.34, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dyne Therapeutics, Inc. (DYN) Snapshot price: $33.03

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 5
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
May 26
Form 4
∞
10.72K
—
—
10.72K
Jul 31 - Sep 21
Form 3
—
0
—
—
0
No matching records found

CRISPR Therapeutics AG (CRSP) Snapshot price: $44.9

CBO & COO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 16
Form 4
+20.03%
4.47K
$61.98
-$192,867.80
26.8K
Mar 10 - Mar 14
Form 4
—
0
—
—
0
Feb 18
Form 4
+226.25%
15.48K
$69.17
-$773,666.45
22.32K
Dec 3 - Dec 6
Form 4
—
0
—
—
0
Oct 15
Form 4
+551.71%
5.79K
$117.86
-$495,837.02
6.84K
Sep 10 - Sep 13
Form 4
-91.95%
-12.00K
$82.04
-$9,635,240.00
1.05K
Scheduled
Mar 23
Form 4
+23.02%
2.44K
$124.15
-$265,805.15
13.05K
Mar 10 - Mar 11
Form 4/A
+153.98%
16.33K
$14.43
$235,699.62
26.94K
Jan 15
Form 4
+0.03%
10
$114.09
-$5,035,164.06
40K
Scheduled
Jan 15
Form 4
-46.96%
-9.39K
$153.11
-$1,438,009.12
10.61K
Jan 2
Form 4
—
0
—
—
0
Oct 5
Form 4
—
0
$42.37
-$4,691,112.98
20K
Scheduled
Jun 24 - Jun 25
Form 4
—
0
$33.13
-$1,363,470.58
20K
Scheduled
May 11
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Dec 3
Form 4
—
0
—
—
0
Sep 10
Form 4
—
0
$27.94
-$883,152.84
20K
Scheduled
Jul 10 - Jul 11
Form 4
—
0
—
—
0
Mar 5
Form 4
∞
20K
$29.87
$597,400.00
20K
Jan 2
Form 3
—
0
—
—
0
No matching records found

Jasper Therapeutics, Inc. (JSPR) Snapshot price: $18.63

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 7
Form 4
∞
24.5K
—
—
24.5K
Oct 12
Form 4
—
0
—
—
0
Mar 21
Form 3
—
0
—
—
0
No matching records found

Oruka Therapeutics, Inc. (ABIO) Snapshot price: $2.48

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found